Bridgeway Capital Management’s Exact Sciences EXAS Stock Holding History

Bridgeway Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-49,500	Closed	-$3.38M	–	1378
2023 Q3	$3.38M	Buy	49,500 +27,900	+129%	+$2.37M	0.08%	379
2023 Q2	$2.03M	Buy	+21,600	New	+$1.68M	0.05%	538
2020 Q3	–	Sell	-23,200	Closed	-$2.02M	–	1331
2020 Q2	$2.02M	Sell	23,200 -3,500	-13%	-$280K	0.04%	412
2020 Q1	$1.55M	Buy	26,700 +3,500	+15%	+$284K	0.04%	426
2019 Q4	$2.15M	Buy	+23,200	New	+$2.04M	0.03%	515

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bridgeway Capital Management's EXAS Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 49,500 shares — an estimated $3.38M sold.

Bridgeway Capital Management first reported a position in EXAS in Q4 2019 and held it in 5 quarters. The position peaked at $3.38M in Q3 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

Bridgeway Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
Bridgeway Capital Management sold 49,500 Exact Sciences shares in Q4 2023, an estimated $3.38M.
Bridgeway Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 5 quarters.
Bridgeway Capital Management's Exact Sciences position peaked at $3.38M in Q3 2023.
647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.